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Purpose of the study
To identify the proportion of patients starting ARV treatment with NNRTIs or with a PI/r and to explore and compare their
clinical profile establishing different factors whereby physicians select the initial ARV treatment in a Spanish clinical setting.
Methods
An observational study was conducted in two different phases. In Phase I a cross-sectional registration was conducted for
patients who initiated ARV treatment in a 6-month period in 65 Spanish hospitals. In Phase II clinical and social-demographic
features were collected retrospectively of patients who visited HIV clinics between August and November 2010 who had started
ARV treatment containing an NNRTIs or a PI/r in Phase I.
Summary of results
In Phase I, 1,687 subjects who initiated ARV treatment were registered, of which 53% started with an NNRTI-based regimen
whereas 42% started with a PI/r-based regimen. Two percent of the treatment initiations occurred in a clinical trial. In Phase II,
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1642 patients were paired consecutively and retrospectively.The group of patients was composed of predominantly male subjects
(81% vs 19%). The median time between diagnosis and the start of ARV treatment was 3.695.3 years. At the initiation of
treatment, 72% of patients had a CD4 count below 350 cells/ml. Although treatment based on NNRTIs in naı ¨ve patients is the
most frequent option in Spain, the analysis of clinical profiles shows that PI/r-based therapy is more often used than NNRTIs
with statistical significance in patients with high viral load, Fig. A (]100.000 copies/ml) (58% vs 42%; OR:1,75; 95% CI: 1,26
2,43; pB0,01), with CD4 cell counts B200 cells/ml, Fig. B (68% vs 31%; OR: 2,92; 95% CI: 1,994,27; pB0,01), and in patients
at CDC stage C (65% vs 35%; OR: 2,05; CI: 1,273,31; pB0,01).
Conclusions
In Spain, HIV is still diagnosed late (as measured by CD4 countB350 cells/ml). Treatment based on NNRTIs are more frequently
used in naı ¨ve patients, although PIs/r-based regimens play an important role being the preferred option in patients with high
viral load (]100.000 copies/ml) and low CD4 cell count (B200 cells/ml).
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